國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Ovarian cancer biomarkersmapping to ...

El Bairi, Khalid.

Ovarian cancer biomarkersmapping to improve outcomes /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Ovarian cancer biomarkersedited by Khalid El Bairi.
其他題名:	mapping to improve outcomes /
其他作者:	El Bairi, Khalid.
出版者:	Singapore :Springer Singapore :2021.
面頁冊數:	xv, 229 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	OvariesCancer
電子資源:	https://doi.org/10.1007/978-981-16-1873-4
ISBN:	9789811618734$q(electronic bk.)

Ovarian cancer biomarkersmapping to improve outcomes /
Ovarian cancer biomarkersmapping to improve outcomes /[electronic resource] :edited by Khalid El Bairi. - Singapore :Springer Singapore :2021. - xv, 229 p. :ill. (some col.), digital ;24 cm.

Chapter 1. General Overview of the Origins and Pathology of Ovarian Cancer -- Chapter 2_An Introduction to the Current Management of Ovarian Cancer in the Era of Precision Oncology -- Chapter 3_The Hallmarks of Ovarian Cancer: Actionable Genetics, Targetable Pathways and Predictive Biomarkers -- Chapter 4_Genetic Alterations in Ovarian Cancer as Prognostic and Predictive Biomarkers of Therapy Response and Surgical Outcomes -- Chapter 5_The Emergence of Circulating Tumor DNA in the Management of Ovarian Cancer -- Chapter 6_Proteomic Biomarkers for Early Detection and Patients' Stratification in Ovarian Cancer -- Chapter 7_Cutting-edge Technologies and Ovarian Cancer.

This book comprehensively summarizes the biology, etiology, and pathology of ovarian cancer and explores the role of deep molecular and cellular profiling in the advancement of precision medicine. The initial chapter discusses our current understanding of the origin, development, progression and tumorigenesis of ovarian cancer. In turn, the book highlights the development of resistance, disease occurrence, and poor prognosis that are the hallmarks of ovarian cancer. The book then reviews the role of deep molecular and cellular profiling to overcome challenges that are associated with the treatment of ovarian cancer. It explores the use of genome-wide association analysis to identify genetic variants for the evaluation of ovarian carcinoma risk and prognostic prediction. Lastly, it highlights various diagnostic and prognostic ovarian cancer biomarkers for the development of molecular-targeted therapy.

ISBN: 9789811618734$q(electronic bk.)

Standard No.: 10.1007/978-981-16-1873-4doiSubjects--Topical Terms:

908378
Ovaries
--Cancer

LC Class. No.: RC280.O8 / O83 2021

Dewey Class. No.: 616.99465

Ovarian cancer biomarkersmapping to improve outcomes /
LDR:02602nmm a2200325 a 4500 001 610337
003 DE-He213
005 20211009075454.0
006 m d
007 cr nn 008maaau
008 220330s2021 si s 0 eng d
020 $a 9789811618734$q(electronic bk.)
020 $a 9789811618727$q(paper)
024 7 $a 10.1007/978-981-16-1873-4 $2 doi
035 $a 978-981-16-1873-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.O8 $b O83 2021
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.99465 $2 23
090 $a RC280.O8 $b O96 2021
245 0 0 $a Ovarian cancer biomarkers $h [electronic resource] : $b mapping to improve outcomes / $c edited by Khalid El Bairi.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2021.
300 $a xv, 229 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Chapter 1. General Overview of the Origins and Pathology of Ovarian Cancer -- Chapter 2_An Introduction to the Current Management of Ovarian Cancer in the Era of Precision Oncology -- Chapter 3_The Hallmarks of Ovarian Cancer: Actionable Genetics, Targetable Pathways and Predictive Biomarkers -- Chapter 4_Genetic Alterations in Ovarian Cancer as Prognostic and Predictive Biomarkers of Therapy Response and Surgical Outcomes -- Chapter 5_The Emergence of Circulating Tumor DNA in the Management of Ovarian Cancer -- Chapter 6_Proteomic Biomarkers for Early Detection and Patients' Stratification in Ovarian Cancer -- Chapter 7_Cutting-edge Technologies and Ovarian Cancer.
520 $a This book comprehensively summarizes the biology, etiology, and pathology of ovarian cancer and explores the role of deep molecular and cellular profiling in the advancement of precision medicine. The initial chapter discusses our current understanding of the origin, development, progression and tumorigenesis of ovarian cancer. In turn, the book highlights the development of resistance, disease occurrence, and poor prognosis that are the hallmarks of ovarian cancer. The book then reviews the role of deep molecular and cellular profiling to overcome challenges that are associated with the treatment of ovarian cancer. It explores the use of genome-wide association analysis to identify genetic variants for the evaluation of ovarian carcinoma risk and prognostic prediction. Lastly, it highlights various diagnostic and prognostic ovarian cancer biomarkers for the development of molecular-targeted therapy.
650 0 $a Ovaries $x Cancer $x Etiology. $3 908378
650 0 $a Ovaries $x Cancer $x Genetic aspects. $3 908379
650 0 $a Biochemical markers. $3 195446
650 1 4 $a Cancer Research. $3 273660
650 2 4 $a Gene Expression. $3 220379
650 2 4 $a Molecular Medicine. $3 273932
700 1 $a El Bairi, Khalid. $3 877008
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-16-1873-4
950 $a Biomedical and Life Sciences (SpringerNature-11642)